The pharmaceutical manufacturer Valeant has a business model of cost-cutting, minimizing expenditures on research and delaying clinical

Question:

The pharmaceutical manufacturer Valeant has a business model of cost-cutting, minimizing expenditures on research and delaying clinical trials. The model has succeeded, as Valeant has become one of the largest pharmaceutical companies in the world, with a market capitalization of $41 billion.
Required
What type of competitive strategy does Valeant employ? Is this strategy sustainable?
Fantastic news! We've Found the answer you've been seeking!

Step by Step Answer:

Related Book For  book-img-for-question

Cost Management A Strategic Emphasis

ISBN: 978-0078025532

6th edition

Authors: Edward Blocher, David Stout, Paul Juras, Gary Cokins

Question Posted: